Myofacial Pain Syndrome
9
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome
Effect of Occlusal Splint on Head and Neck Muscles in Patients With Bruxism and Myofascial Pain
Artificial Intelligence Clinical Decision
Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain
Extracorporeal Shock-wave Therapy in Myofascial Pain Syndrome
The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome
Intramuscular Electrical Stimulation on Upper Trapezius With Trigger Points
Botulinum Toxin A in Patients With Myofascial Pain Syndrome With and Without Zinc Supplementation
The Effect of Low Level Laser Therapy (LLLT) in Myofacial Pain Syndrome